Showing results (601-610 of 631) with videos related to
Sort By:
Pageof 64
Particle and Fibre Toxicology|February 11, 2014
Sub-chronic toxicity study in rats orally exposed to nanostructured silicaMeike van der Zande, Rob J Vandebriel, Maria J Groot, et al.Actas Dermo-Sifiliograficas|July 5, 2015
Does the treatment ladder for systemic therapy in moderate to severe psoriasis only go up? The percentage of patients with severe psoriasis on biologics increases over timeJ M Carrascosa, N Rivera, I Garcia-Doval, et al.Environmental Toxicology and Chemistry|December 10, 2013
Effects of silver nanoparticles (NM-300K) on Lumbricus rubellus earthworms and particle characterization in relevant test matrices including soilMerel J C van der Ploeg, Richard D Handy, Pauline L Waalewijn-Kool, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|September 5, 2014
Safety of classic and biologic systemic therapies for the treatment of psoriasis in elderly: an observational study from national BIOBADADERM registryC Medina, G Carretero, C Ferrandiz, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|April 2, 2014
Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a 5-year observational study of clinical practice: 2008-2013 results of the Biobadaderm registryG Carretero, C Ferrandiz, E Dauden, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|June 23, 2016
Survival of classic and biological systemic drugs in psoriasis: results of the BIOBADADERM registry and critical analysisP Dávila-Seijo, E Dauden, G Carretero, et al.Genetic Testing and Molecular Biomarkers|April 8, 2022
Improved HUMARA for the Detection of X-Linked Agammaglobulinemia CarriersEduardo Carrillo-Tapia, Sara E Espinosa-Padilla, Daniela Perez-Perez, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|May 10, 2017
Adverse events associated with discontinuation of the biologics/classic systemic treatments for moderate-to-severe plaque psoriasis: data from the Spanish Biologics Registry, BiobadadermI Belinchón, J M Ramos, G Carretero, et al.Actas Dermo-Sifiliograficas|May 24, 2014
Evidence-based guidelines of the spanish psoriasis group on the use of biologic therapy in patients with psoriasis in difficult-to-treat sites (nails, scalp, palms, and soles)M Sánchez-Regaña, M J Aldunce Soto, I Belinchón Romero, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|March 3, 2017
Comparison of phenotype, comorbidities, therapy and adverse events between psoriatic patients with and without psoriatic arthritis. Biobadaderm registryA Pérez-Plaza, G Carretero, C Ferrandiz, et al.Pageof 64